Imicrit 250mg/250mg Injection
Marketer
Cipla Ltd
Salt Composition
Imipenem (250mg) + Cilastatin (250mg)
Overview Imicrit 250mg/250mg Injection
Combiflox 250mg/250mg Injection, a dual-antibiotic formulation, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to prevent infection spread. Complete the prescribed course, even with symptom improvement; missed doses should be avoided. Commonly reported side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) are usually transient. Severe side effects necessitate immediate medical consultation. Seek emergency care for allergic reactions (rash, itching, swelling, breathing difficulty). Inform your doctor of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Imicrit 250mg/250mg Injection
The provided text is "undefined," which has no meaning to rephrase. Therefore, no rewritten text can be provided.
Uses of Imicrit 250mg/250mg Injection
Life-threatening bacterial infestations
Major Benefits of Imicrit 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Imicrit 250mg/250mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Imicrit 250mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Imicrit 250mg/250mg Injection works:
Imicrit, a 250mg/250mg injectable formulation, unites imipenem, a bacterial growth inhibitor, with cilastatin, a dehydropeptidase I inhibitor. Imipenem's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Cilastatin's role is to protect imipenem from degradation by dehydropeptidase I, thereby extending its therapeutic effectiveness within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Imicrit 250mg/250mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Imicrit 250mg/250mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any possible hazards prior to its prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Imicrit 250mg/250mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingUNSAFE
Administering Imicrit 250mg/250mg Injection may induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impair some patients' ability to operate a vehicle.
KidneyCAUTION
Imicrit 250mg/250mg Injection requires careful administration in individuals with impaired renal function. Dosage modification of Imicrit 250mg/250mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Imicrit 250mg/250mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Imicrit 250mg/250mg Injection :
Should you inadvertently omit a scheduled dose of Imicrit 250mg/250mg Injection, seek advice from your physician.
Facts to Know About Imicrit 250mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently